THE USE OF BUCILLAMINE IN THE TREATMENT OF GOUT

摘要

Disclosed are pharmaceutical compositions comprising, bucillamine, including bucillamine and allopurinol or colchicine, or pharmaceutically acceptable salts or solvates thereof, together with one or more pharmaceutically acceptable carriers, diluents and excipients. Methods for use of the said compositions in the treatment of gout and metabolic syndrome are also disclosed.

主权项

1. A pharmaceutical composition comprising bucillamine or a pharmaceutically acceptable salt or solvate thereof, together with one or more pharmaceutically acceptable carriers, diluents and excipients, for use in the treatment or prevention of gout, and/or the attenuation of metabolic syndrome.